1. NAME OF THE MEDICINAL PRODUCTSodium cromoglicate Powder

2. QUALITATIVE AND QUANTITATIVE COMPOSITIONThe active component of Intal Powder is only sodium cromoglicate 20mg/capsule

3. PHARMACEUTICAL FORMNo excipient

4. Therapeutic indicationsIt is indicated for the preventative treatment of bronchial asthma, in adults and children.

5.Preclinical safety dataPre-clinical data reveal no special hazard for humans based on studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction.

6. PACKAGING INFORMATION Sales pack contains 30 Capsule